MT-ATP6 and prostate carcinoma: Abril et al. demonstrated that the RNA levels of MT-RNR1, MT-CO2, and MT-ATP6 were downregulated in prostate cancer compared to paired normal tissue, suggesting that MT-RNR1 may be involved in prostate cancer progression [12].